NivolumabThyroid dysfunction and lack of efficacy

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2023年 / 1984卷 / 1期

关键词：

D O I：

10.1007/s40278-023-50639-3

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：408 / 408

相关论文

共 50 条

[1] NivolumabThyroid dysfunction and lack of efficacy: 4 case reports
Reactions Weekly, 2022, 1917 (1) : 456 - 456
[2] NivolumabThyroid dysfunction: case report
Reactions Weekly, 2018, 1702 (1) : 194 - 194
[3] NivolumabThyroid dysfunction: case report
Reactions Weekly, 2023, 1973 (1) : 229 - 229
[4] NivolumabThyroid dysfunction: 2 case reports
Reactions Weekly, 2018, 1731 (1) : 195 - 195
[5] NivolumabThyroid dysfunction: 3 case reports
Reactions Weekly, 2017, 1633 (1) : 562 - 562
[6] Multiple drugsRenal dysfunction and lack of efficacy
Reactions Weekly, 2024, 2006 (1) : 494 - 494
[7] Acetylcysteine/sevofluraneLiver dysfunction and lack of efficacy
Reactions Weekly, 2024, 2009 (1) : 19 - 19
[8] NivolumabThyroid dysfunction and isolated adrenocorticotropin deficiency: case report
Reactions Weekly, 2021, 1880 (1) : 305 - 305
[9] NivolumabThyroid dysfunction in the form of hypothyroidism and hyperthyroidism: 21 case reports
Reactions Weekly, 2020, 1827 (1) : 261 - 261
[10] Ipilimumab/Midodrine/NivolumabPituitary dysfunction and lack of efficacy
Reactions Weekly, 2023, 1984 (1) : 280 - 280

← 1 2 3 4 5 →